A Study of Ustekinumab or Guselkumab in Pediatric Participants With Active Juvenile Psoriatic Arthritis
Clinical trial NCT05083182 · COMPLETED
Trial details
- NCT number
- NCT05083182
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-30
- Primary completion
- 2026-01-12
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.